COCP Flashcards
16-66 (40) pages long and has quiz at end of document
What synthetic oestrogen is used in CHC
Ethinylestradiol (EE)
What types of CHC are available
Pill (COC)
Vaginal ring (CVR)
Transdermal patch (CTP)
Health risks and give figures
Increased risk of serious health events including:
1. Venous and arterial thromboembolism (minimised by using <30micrograms of ethinylestradiol) - PE/DVT / stroke/MI
- use of COC is assoc with x3 increased risk. NB- absolute risk of VTE in CHC women = 5-12 per 10’000/ year (with 1% mortality) compared to 2 per 10’000/ year non-CHC users. VTE risk is lower during CHC than during pregnancy. Risk highest in months starting, reduces after.
- Breast cancer- small increased risk (RR 1.19 for current users vs never-users), reduces with time after stopping [same as normal after 10y]
- Cervical cancer - current COC use >5y, doubles risk. Returns to normal after 10y (and prob 5y). No evidence with patch or ring.
Health benefits
Reduced risk of the following cancers:
1. Endometrial cancer*
2. Ovarian cancer*
3. Colorectal cancer
- significant reduction in risk that increases with duration of use and persists for many years after stopping CHC
Other benefits:
1. Predictable bleeding patterns
2. Reduction in heavy menstrual bleeding and pain
3. Management of symptoms of PCOS (acne, hirsutism, menstrual irregularities)
4. Reduce risk of endometriosis recurrence after surgical management [continuous regimen]
5. Improve PMS symptoms
6. Improve acne
Side effects + important things to explain in consult
- Mood change [mixed evidence]
- Headache
- Unscheduled bleeding [assoc with lower levels of oestrogen], likely to improve within 3-4 months
Other associated - nausea, dizziness, br tenderness - often assoc with HFI so advise this if experiencing.
Explain:
- Missed pills advice
- COC effectiveness could be reduced by vomiting or severe diarrhoea. Follow advice for missed pills if vomitting occurs within 3h of taking COC or if severe diarrhoea occurs for >24h
CHC regimens - any benefit in difference?
Traditional 21/7 with monthly withdrawal bleed confers no health benefit over other patterns. HFI risks escape ovulation particularly with lower dose EE and if use is not perfect. Tailor to patient.
Drug interactions
- Hepatic enzyme-inducing drugs could reduce the contraceptive effectiveness of all CHC methods
- CHC can affect serum levels of drugs such as lamotrigine with potential significant SE’s
How much can supply at once?
How regularly follow ups?
Up to a years supply at first consultation (although only 3mo of vaginal ring can be supplied at one time). Annual f/u with r/v of medical eligibility, drug interactions, compliance and consideration of alternative contraception incl LARC is recommended as routine.
Fertility issues?
CHC not assoc with a delay in return to fertility after stopping
Maximum period of CHC use / maximum age?
No arbitrary maximum period of CHC use. Repeated stopping and starting should be discouraged because of thrombotic risk. Can use up to age 50 for contraception / menopausal symptoms and maintenance of BMD.
The majority of CHC contain how much synthetic oestrogen?
Between 20 micrograms and 35 micrograms.
This ‘low-dose’ was developed to reduce the health risks assoc with high oestrogen content of COC available in 1960s/70s.
Benefits of progestogens in CHC
Progestogens are synthetic steroids
- convenient dosing intervals
- potent suppression of ovulation
- prevents over-proliferation of the endometrium in response to oestrogen
1st, 2nd, 3rd, newer generation progestogens
First: norethisterone
Second: levonorgestrel
Third: desogestrel, gestodene, norgestimate
Newer: drospirenone, dienogest, nomegestrol acetate
Norelgestromin (used in patch) is a metabolite of norgestimate
Etonogestrel (used in vaginal ring) is the active metabolite of desogestrel
Combined transdermal patch releases how much EE and progestogen per day?
EE - 33.9 micrograms
Norelgestromin - 200microgram
per 24h
Combined vaginal ring releases how much EE and progestogen per day?
EE - 15 microgram
Etonogestrel - 120microgram
per 24h
How does CHC work?
- Primary mechanism is by prevention of ovulation
- CHC acts on the hypothalamo-pituitary-ovarian axis to suppress LH and FSH and thus inhibit ovulation
- Cervical mucus, endometrium and tubal motility that result from progestogen exposure may also contribute to the contraceptive effect.
You can take CHC in a number of ways. Traditionally with a HFI of 7 days. Tell me the drawbacks of this.
21/7 cycles were designed to mimick natural cycles with a bleed however there is no health benefit to this and the 7d HFI has drawbacks:
- bleeding may be heavy/ painful/ unwanted
- may get headaches and mood change
- ovarian suppression is reduced and follicular development occurs in the HFI. Errors in pill taking / patch / ring use could result in extension of the HFI = risk of ovulation= risk of pregnancy
Using tailored use (no break, multiple packs and then a break, a shorter break) is off license but supported by FSRH
Describe the standard CHC regimens (with pill / patch / ring)
Pill - 21 days of pill, 7d break. First 7 pills inhibit ovulation, remaining 14 maintain anovulation.
Patch - as above but a patch lasts 7d. Use 3. Then patch free week.
Ring - leave vaginal ring in for 21d, then 7d ring free period.
During HFI withdrawal bleed due to endometrial shedding. Be clear this is not physiological menstruation and has no health benefit.
Give e.g.s of tailored regimens
Drawbacks of these
-4d HFI
- Tricycling - 3x 21 active pills / 3 rings / 9 patches consecutively then 4 or 7d break
- Flexible extended use - continuous use until breakthrough bleed then have a 4d break
- Continuous use with no breaks
Drawbacks of continued use is that you are more likely to get breakthrough/ unscheduled bleeding
In theory it reduces the risk of escape ovulation which is good
When can you start CHC
- Up to and including day 5 of a natural menstrual cycle without the need for additional protection
- At any other time in the cycle with additional contraception for 7 days PROVIDING THAT:
- it is reasonably certain a woman is not pregnant
- a high sensitivity urine preg test is negative (even if risk from past 21d). f/u PT required after 21d from UPSI.
Almost all of the available evidence suggests no adverse impact of fetal exposure to contraceptive hormones on pregnancy outcomes or risk of fetal abnormality. Note that starting CHC should be delayed for 5d after ulpristal acetate EC.
EC - levenogestrel, advice for starting COC vs.
ulpristal acectate EC
levenogestrel
- can start immediately
- use additional protection for 7d
ulpristal acetate [ella one]
- wait 5d
- after the 5d use additional protection for 7d